An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall
Breast Cancer
About this trial
This is an interventional diagnostic trial for Breast Cancer focused on measuring Stereoscopic digital mammography, Breast cancer detection, Reduced rate of recall, Focal abnormalities detection
Eligibility Criteria
Personal risk factors (any of the following) Personal history of breast and/or ovarian cancer, regardless of age. Prior breast biopsy that included any of the following high risk, benign lesion: Lobular carcinoma in-situ, Atypical ductal hyperplasia, Atypical lobular hyperplasia, Atypical columnar hyperplasia. Positive test for known mutations of BRCA 1 or 2 genes, regardless of age. History of chest irradiation for treatment of non-breast disease (EX:lymphoma, lung cancer) at least 15 years prior to enrollment. Family history (over 30 years of age with any of the following, some exceptions may appy) Ashkenazi Jewish ancestry, regardless of age. Any history of male breast cancer on the maternal or paternal side. Breast and ovarian cancer in a close relative (mother, sister, daughter) Breast or ovarian cancer in more than one close relative (mother,sister daughter) Breast cancer in a close relative (mother, sister, daughter) with early onset(<50 years of age) Breast and ovarian cancer in a 2nd. degree relative (grandmother, aunt, niece) with early onset of breast cancer. (<50 years of age) Multiple history of breast cancer in 1st. and 2nd. degree relatives. Exclusion Criteria: Patient does not meet any of the inclusion criteria, Patient has had breast augmentation, except for unilateral augmentation done for prior mastectomy, Patient has suspected or confirmed pregnancy, Patient has large breasts that cannot be adequately imaged on the 19 x 23 cm detector surface of the GE Senographe 2000D digital mammography unit.
Sites / Locations
- Emory University Hospital